John Feneck, portfolio manager and consultant at Feneck Consulting, shared his thoughts on gold’s post-US election price drop, saying it doesn’t mean the metal won’t thrive once Donald Trump takes office again. Feneck also gave updates on mining stocks he’s watching right now. On the gold side, he mentioned companies…
Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas…
Jindalee Lithium Limited (Jindalee, the Company; ASX: JLL, OCTQX: JNDAF) is pleased to advise that its recently completed Pre-Feasibility…
The Russian government has imposed temporary restrictions on enriched uranium exports to the US. Announced on November 15, the…
Ionic Rare Earths Limited (“IonicRE” or the “Company”) (ASX: IXR) wholly owned subsidiary Ionic Technologies is on track for…
Perth, Australia (ABN Newswire) – BPH Energy Limited (ASX:BPH) provide a presentation by investee Cortical Dynamics at the Health…
Australian antiviral drug development company, Island Pharmaceuticals Ltd (ASX: ILA; Island or the Company) is pleased to announce progress…
Description During a fireside chat with analysts from Brookline Capital Markets, Radiopharm Theranostics’ (ASX:RAD) CEO Riccardo Canevari provided clinical…
Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas…